PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

The anti-inflammatory and anti-oxidative actions of eugenol improve lipopolysaccharide-induced lung injury.

Mouse / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 29997055 ↗2018Reported benefit

The anti-inflammatory and anti-oxidative actions of eugenol improve lipopolysaccharide-induced lung injury.

MouseEndotoxin/LPSBALB/cMaleSeveral doses tested with a dose-dependent effect; mechanis…

Model: Lipopolysaccharide-induced acute lung injury, with lung mechanics and histology analysed 24 h after exposure

Eugenol improved lipopolysaccharide-induced lung functional and histological changes in a dose-dependent way, and at 150 mg/kg inhibited release of inflammatory cytokines, NADPH oxidase activity and protein oxidation.

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.